AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.7298
+0.0753 (11.50%)
At close: Jun 5, 2025, 4:00 PM
0.7270
-0.0028 (-0.38%)
Pre-market: Jun 6, 2025, 4:43 AM EDT

AEON Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Operating Revenue
-----2.52
Upgrade
Revenue
-----2.52
Upgrade
Revenue Growth (YoY)
------24.99%
Upgrade
Gross Profit
-----2.52
Upgrade
Selling, General & Admin
12.1213.6419.7913.6811.1511.59
Upgrade
Research & Development
9.2714.1833.0534.7525.737.32
Upgrade
Operating Expenses
21.3927.8252.8448.4336.8818.91
Upgrade
Operating Income
-21.39-27.82-52.84-48.43-36.88-16.39
Upgrade
Interest Expense
------0.02
Upgrade
Other Non Operating Income (Expenses)
20.68-34.29-17.190.29-0.14-0.12
Upgrade
EBT Excluding Unusual Items
-0.72-62.12-70.02-48.14-37.02-16.52
Upgrade
Gain (Loss) on Sale of Investments
-----0.35
Upgrade
Legal Settlements
-----28.97-
Upgrade
Other Unusual Items
169.83104.1233.39-4.4210.35-16.74
Upgrade
Pretax Income
169.1242.01-384.63-52.56-55.64-32.91
Upgrade
Earnings From Continuing Operations
169.1242.01-384.63-52.56-55.64-32.91
Upgrade
Net Income
169.1242.01-384.63-52.56-55.64-32.91
Upgrade
Preferred Dividends & Other Adjustments
-----17.26
Upgrade
Net Income to Common
169.1242.01-384.63-52.56-55.64-50.17
Upgrade
Shares Outstanding (Basic)
2177220
Upgrade
Shares Outstanding (Diluted)
2177220
Upgrade
Shares Change (YoY)
-97.00%-99.25%3896.62%9.98%1813.85%-0.74%
Upgrade
EPS (Basic)
74.3877.74-4.99-27.25-31.73-547.60
Upgrade
EPS (Diluted)
73.2372.93-4.99-27.25-31.73-547.60
Upgrade
Free Cash Flow
-19.61-20.29-47.83-35.89-28.6-9.46
Upgrade
Free Cash Flow Per Share
-8.49-35.23-0.62-18.61-16.31-103.26
Upgrade
Gross Margin
-----100.00%
Upgrade
Operating Margin
------650.83%
Upgrade
Profit Margin
------1992.53%
Upgrade
Free Cash Flow Margin
------375.74%
Upgrade
EBITDA
-21.3-27.73-52.74-48.36-36.88-15.51
Upgrade
D&A For EBITDA
0.090.10.10.0700.88
Upgrade
EBIT
-21.39-27.82-52.84-48.43-36.88-16.39
Upgrade
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q